Study of the Correlation Between Donor CIRBP and Transplanted Kidney Function
1 other identifier
observational
207
1 country
1
Brief Summary
Deceased donors and recipients who successfully completed kidney transplantation between 2016 and 2019 were included in this study. Donor plasma CIRBP levels were measured using an ELISA kit to evaluate their association with DGF incidence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2024
CompletedFirst Submitted
Initial submission to the registry
October 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedOctober 15, 2024
October 1, 2024
8 months
October 10, 2024
October 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
recipients developed delayed graft function
DGF was defined as a decrease in daily plasma creatinine of less than 10% from the previous day for 3 consecutive days within 1 week postoperatively, or if serum creatinine (SCr) did not decrease to 400 μmol/L within 1 week after surgery
within 1 week after surgery
Study Arms (2)
delayed graft function
DGF was defined as a decrease in daily plasma creatinine of less than 10% from the previous day for 3 consecutive days within 1 week postoperatively, or if serum creatinine (SCr) did not decrease to 400 μmol/L within 1 week after surgery
immediate graft function
Recipients who did not develop DGF were categorized as IGF
Interventions
Donor plasma CIRBP levels were measured using an ELISA kit to evaluate their association with DGF incidence
Eligibility Criteria
Our study was a retrospective open cohort study that included deceased patients from January 2016 to December 2019. It adhered to the guidelines of the National Program for Deceased Organ Donation in China and involved successful kidney donors from the Third Affiliated Hospital of Sun Yat-sen University.
You may qualify if:
- Kidney donors who meet the criteria for donation;
- First-time kidney transplant recipients;
- Transplantation using cadaveric donor kidneys;
- Signing of the Human Organ Donation Relative Acknowledgement Registration Form.
You may not qualify if:
- those without a blood specimen;
- contamination of the blood specimen affecting the CIRBP level;
- recipients of combined multi-organ transplants;
- those participating in other clinical trials;
- the existence of a previous history of other organ transplants;
- any other condition that, in the opinion of the investigator, makes enrolment unsuitable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510000, China
Related Publications (2)
Yang R, Zhan M, Nalabothula NR, Yang Q, Indig FE, Carrier F. Functional significance for a heterogenous ribonucleoprotein A18 signature RNA motif in the 3'-untranslated region of ataxia telangiectasia mutated and Rad3-related (ATR) transcript. J Biol Chem. 2010 Mar 19;285(12):8887-93. doi: 10.1074/jbc.M109.013128. Epub 2010 Jan 26.
PMID: 20103595BACKGROUNDLeng Q, Ma M, Tang Z, Jiang W, Han F, Huang Z. Assessing donor kidney function: the role of CIRBP in predicting delayed graft function post-transplant. Front Immunol. 2025 Jan 17;15:1518279. doi: 10.3389/fimmu.2024.1518279. eCollection 2024.
PMID: 39896811DERIVED
Biospecimen
blood sample
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Qianghua Leng
Third Affiliated Hospital, Sun Yat-Sen University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 10, 2024
First Posted
October 15, 2024
Study Start
December 1, 2023
Primary Completion
August 10, 2024
Study Completion
October 10, 2024
Last Updated
October 15, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- March 2025, for 3 years
Share the data on Public management platform for clinical trials ResMan